Center for Scientific Review; Amended Notice of Meeting, 52051 [2015-21269]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 166 / Thursday, August 27, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
September 24, 2015, 10:00 a.m. to
September 24, 2015, 6:00 p.m., National
Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD, 20892 which was
published in the Federal Register on
August 17, 2015, 80 FR 49252.
The meeting will be held on October
21, 2015. The meeting location and time
remain the same. The meeting is closed
to the public.
Dated: August 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Agenda: Discussion of personnel matters
and/or issues of which the premature
discloser may affect outcomes.
Place: National Institutes of Health,
Building 10, CRC Medical Board Room 4–
2551, 10 Center Drive, Bethesda, MD 20892.
Contact Person: Maureen E. Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892 (301) 496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
AGENCY:
2015. This test will continue until
concluded by way of announcement in
the Federal Register. Public comments
are invited and will be accepted through
the duration of the test pilot.
ADDRESSES: Comments concerning this
notice and any aspect of this test may
be submitted at any time during the test
via email to Josephine Baiamonte, ACE
Business Office (ABO), Office of
International Trade, at
josephine.baiamonte@cbp.dhs.gov. In
the subject line of your email, please
indicate, ‘‘Comment on FDA PGA
Message Set Test FRN’’.
FOR FURTHER INFORMATION CONTACT: For
PGA-related questions, contact
Elizabeth McQueen at
elizabeth.mcqueen@cbp.dhs.gov. For
technical questions related to the
Automated Commercial Environment
(ACE) or Automated Broker Interface
(ABI) transmissions, contact your
assigned client representative.
Interested parties without an assigned
client representative should direct their
questions to Steven Zaccaro at
steven.j.zaccaro@cbp.dhs.gov with the
subject heading ‘‘PGA Message Set FDA
Test FRN-Request to Participate.’’ For
FDA-related questions, contact Sandra
Abbott at sandra.abbott@fda.hhs.gov or
Max Castillo at max.castillo@
fda.hhs.gov.
Any party seeking to participate in
this test must provide CBP, in its
request to participate, its filer code and
the port(s) at which it is interested in
filing the appropriate PGA Message Set
information. At this time, PGA Message
Set data may be submitted only for
entries filed at certain ports. A current
listing of those ports may be found at
the following link: https://www.cbp.gov/
document/guidance/list-aceitds-pgamessage-set-pilot-ports.
SUPPLEMENTARY INFORMATION:
This document announces
U.S. Customs and Border Protection’s
(CBP’s) plan to conduct a National
Customs Automation Program (NCAP)
test concerning the electronic
transmission of certain import data for
all Food and Drug Administration
(FDA)-regulated commodities. Under
the pilot, this data will be transmitted
electronically through the Automated
Broker Interface (ABI) for processing in
CBP’s Automated Commercial
Environment (ACE) system utilizing the
Partnering Government Agency (PGA)
Message Set.
DATES: The FDA PGA Message Set test
will begin no earlier than August 27,
I. Background
The National Customs Automation
Program (NCAP) was established in
Subtitle B of Title VI—Customs
Modernization (Customs Modernization
Act), in the North American Free Trade
Agreement Implementation Act, Public
Law 103–182, 107 Stat. 2057 (19 U.S.C.
1411). Through NCAP, the initial thrust
of customs modernization was on trade
compliance and the development of the
Automated Commercial Environment
(ACE), the planned successor to the
Automated Commercial System (ACS).
ACE is an automated and electronic
system for processing commercial trade
data which is intended to streamline
business processes, facilitate growth in
trade, ensure cargo security, and foster
participation in global commerce, while
BILLING CODE 4140–01–P
Dated: August 21, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–21222 Filed 8–26–15; 8:45 am]
[FR Doc. 2015–21269 Filed 8–26–15; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HOMELAND
SECURITY
Clinical Center; Notice of Meeting
rmajette on DSK2VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as amended
because the premature disclosure of to
discuss personnel matters and the
discussions would likely to significantly
frustrate implementation of
recommendations.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: September 28, 2015.
Open: 10:00 a.m. to 1:00 p.m.
Agenda: Discussion of intramural clinical
research operational and funding issues.
Place: National Institutes of Health,
Building 10, CRC Medical Board Room 4–
2551, 10 Center Drive, Bethesda, MD 20892.
Closed: 1:00 p.m. to 2:00 p.m.
VerDate Sep<11>2014
15:08 Aug 26, 2015
Jkt 235001
52051
U.S. Customs and Border Protection
Modification of National Customs
Automation Program (NCAP) Test
Concerning the Submission of Certain
Data Required by the Food and Drug
Administration (FDA) Using the Partner
Government Agency (PGA) Message
Set Through the Automated
Commercial Environment (ACE)
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 80, Number 166 (Thursday, August 27, 2015)]
[Notices]
[Page 52051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21269]
[[Page 52051]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Center for
Scientific Review Special Emphasis Panel, September 24, 2015, 10:00
a.m. to September 24, 2015, 6:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the
Federal Register on August 17, 2015, 80 FR 49252.
The meeting will be held on October 21, 2015. The meeting location
and time remain the same. The meeting is closed to the public.
Dated: August 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-21269 Filed 8-26-15; 8:45 am]
BILLING CODE 4140-01-P
